Evidence map›Paper›PMID 27701401›Full record

ArticleMolecular therapy. Nucleic acids2016

The Functionality of Minimal PiggyBac Transposons in Mammalian Cells.

Boris Troyanovsky, Vira Bitko, Viktor Pastukh, Brian Fouty, Victor Solodushko

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Regenerative base editing enables deep lineage recording.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Applications ofStem cells international · 2021
    Review
  11. Review
  12. Pharmaceutics · 2020
    Review
  13. In VivoInternational journal of molecular sciences · 2019
    Article
  14. Article
  15. RNA-guidedSynthetic biology (Oxford, England) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Boris TroyanovskyDepartment of Pharmacology, University of South Alabama School of Medicine, Mobile, Alabama, USA.
Vira BitkoNanoBio Corporation, Ann Arbor, Michigan, USA.
Viktor PastukhDepartment of Pharmacology, University of South Alabama School of Medicine, Mobile, Alabama, USA.
Brian FoutyDepartment of Pharmacology, University of South Alabama School of Medicine, Mobile, Alabama, USA.
Victor SolodushkoDepartment of Pharmacology, University of South Alabama School of Medicine, Mobile, Alabama, USA.
University of South Alabama · USNanoBio (United States) · US

Funding

Minimal piggyBac vectors for chromatin integrationR41GM109527 · NIGMS · EXSCIEN CORPORATION · PI SOLODUSHKO, VICTOR · 2014 to 2014
$151k
NIGMS NIH HHS R41 GM109527
6 · The paper itself

Abstract

Minimal piggyBac vectors are a modified single-plasmid version of the classical piggyBac delivery system that can be used for stable transgene integration. These vectors have a truncated terminal domain in the delivery cassette and thus, integrate significantly less flanking transposon DNA into host cell chromatin than classical piggyBac vectors. Herein, we test various characteristics of this modified transposon. The integration efficiency of minimal piggyBac vectors was inversely related to the size of both the transposon and the entire plasmid, but inserts as large as 15 kb were efficiently integrated. Open and super-coiled vectors demonstrated the same integration efficiency while DNA methylation decreased the integration efficiency and silenced the expression of previously integrated sequences in some cell types. Importantly, the incidence of plasmid backbone integration was not increased above that seen in nontransposon control vectors. In BALB/c mice, we demonstrated prolonged expression of two transgenes (intracellular mCherry and secretable Gaussia luciferase) when delivered by the minimal piggyBac that resulted in a more sustained antibody production against the immunogenic luciferase than when delivered by a transient (nontransposon) vector plasmid. We conclude that minimal piggyBac vectors are an effective alternative to other integrative systems for stable DNA delivery in vitro and in vivo.

Identifiers

PMID27701401
PMCPMC5095681
OpenAlexW2528171099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.